October 27, 2022
October 27, 2022 —
UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.
October 26, 2022
October 26, 2022 —
Researchers at UC San Diego have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.
October 25, 2022
October 25, 2022 —
Building upon a long history, the UC San Diego has launched a new Human Milk Institute to accelerate research into the biology and therapeutic potential of human milk to prevent or treat both infant and adult diseases. The new institute is believed to be the first of its kind in the United States.
October 24, 2022
October 24, 2022 —
Using a novel systems biology approach, scientists at UC San Diego School of Medicine have further parsed the cellular players and roles involved in rheumatoid arthritis, a complex disease that affects more than one million Americans in ways that have defied development of uniform treatments.
October 20, 2022
October 20, 2022 —
During October’s Breast Cancer Awareness Month, a breast cancer survivor and UC San Diego Health employee shares her personal experiences from the moment of diagnosis and receiving life-saving care, to the important lessons she has learned along the journey.
October 19, 2022
October 19, 2022 —
UC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial cancer that could safely avoid removal of the entire kidney, which may prevent the need for dialysis or kidney transplant in the future.
October 18, 2022
October 18, 2022 —
Victor Nizet, MD, Distinguished Professor of Pediatrics at University of California San Diego School of Medicine and Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences, has been elected to the National Academy of Medicine.
October 12, 2022
October 12, 2022 —
Alexander A. Khalessi, MD, MBA, chair of neurosurgery at UC San Diego Health, has been chosen as 2023 president-elect of the Congress of Neurological Surgeons.
October 11, 2022
October 11, 2022 —
UC San Diego scientists are leading a national early-stage clinical trial to assess the safety and efficacy of using bacteriophages to treat drug-resistant bacterial infections in cystic fibrosis patients.
October 10, 2022
October 10, 2022 —
More than 100 UC San Diego Health physicians have been named “Top Docs” in the 2022 San Diego Magazine “Physicians of Exceptional Excellence” survey.
